Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, rbtree is perfectly reasonable and knows what's what about these 2 partnered stocks. You oughta try & learn something.
Yep, they still need to get their financial sh*t together before any uplisting can be considered.
Is that supposed to be impressive or mean something to us traders?
Low Volume is good when Selling is the trend. On those Hi-Volume days, most of it was Buying.
The slide continues today over at Swiss RLF. Fitbit is telling it like it is.
That's for sure! I own WDLF from early on & am holding for long.
Given the pandemic & All that the FDA is dealing with, the 'normal' rules, like a 30-day response time, don't necessarily apply. So, a delayed response time here is to be expected.
New Mexico
Look it up on Google.
Yes, I've read All of CELZ PRs very closely. This PR was released previously in Dec. for a different indication. It's nothing really new except for the specific indication.
I was responding to the comment that the sp can go past .25 today. That is delusional.
CELZ has already submitted an IND to the FDA for Stroke Clinical Trial last month. If/when FDA gives them the go-ahead, CELZ is really going to launch!
You meant "bought a lot" 'Lower', right? Not "Higher". I hope so, for your sake.
JDrais, you've nailed it about ENZC's valuable antibody technology. Also several yrs back, Dr. Fauci/the Govt. was vying for the rights to this antibody tech, but Enzolytics won out in the end.
Thanks for sharing this valuable link to a great analysis of the Trial's Prelim. Results.
Not such a "bold assumption"; it's rather plausible given that prelim. results were released soon after Board Dir. Burkhardt was 'canned'. Releasing 'prelim. results' before expected release of Topline Results is actually very unconventional for a clinical trial.
Lotsaluck2000 is Correct; the 2 study arms are not the same size. Zyesami has about 2x the # of Pts. as Placebo. So, the results for both were actually about equal.
Your comparing the # of Pts. from both arms is misleading.
Apparently you missed the part of NeuroRx's prelim. report that the Trial's Primary Endpt. of 28-day Survival DID NOT Show Any Improvement over Placebo. If that's not "negative", I don't know what is. Plus, the steep dive in sp oughta tell you something if the PR didn't.
The best time to invest in a biotech is at the early stage of drug development when there's seen to be great potential for the drug as an innovative or effective treatment for the disease or condition. That's when the sp is very low & shoots up on any PR that's seen as positive. Such as CELZ or ENZC.
Some of your questions are answered in the new PR & will be answered in the upcoming March Conf. Call.
Didn't the new PR say the earlier Reg. A was cancelled?
I'm headed for that cabin in the woods! Lol!
Good work! Thanks for your proactive-ness!
That's for sure!
Small cup & handle forming on chart. Good sign.
Good to have you aboard.
You just ignore it and continue to hold strong!
What an extremely volatile Open! I'm holding strong, tho!
Bernard Baruch's advice is very wise for the 'worriers'.
These are only prelim. results. That is a positive result but didn't meet Stat. Significance as you had stated.
You must've missed the line that said All patients were given either Remdesavir or other treatments, incl. SOC patients.
You're Incorrect. These preliminary results Did Not Meet Statistical Significance.
But the silver lining is that there is No Other Approved Therapeutic for treating Critical Covid-19 Pts. So, this result can be seen as a Favorable one.
The success of a Clinical Trial is based on meeting its Primary Endpt. Relief didn't do that with this Trial; Only met 2ndary Endpt.
That's correct. The Survival results favored SOC over Zyesami! Thus, the Big Dive in SP Now!
You missed the line that said All of the patients were given Remdesavir among other treatments, incl. in SOC.
You might have something there. I was wondering why a Board Member would resign right when the most pivotal event in the Co.'s history is about to happen. Could he have been forced out for some reason?
Why is it that you Always OVERREACT to every piece of news about Relief/NeuroRx?
I think that's what happened; Dr. J. let the cat out of the bag this past weekend, maybe purposely, since it drives up BRPA-merger stock as well.
Done!